Sign in
CompletedNo phase

HCV Microfluidic Diagnostics

Key facts

Who runs it
University of Hull
Where
United Kingdom1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
38 people enrolled
Started
1 May 2023
Ended
31 Mar 2024
Type of study
Observational, 2 groups
Record updated
10 July 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Blood sample taken

Who cannot take part

  • None

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Hepatitis C diagnostic devices have been developed at the University of Hull to detect and quantify the Hepatitis C virus in patients' plasma and serum samples. This study aims to test the new point-of-care devices that are designed to be low cost and user-friendly.

Read full original descriptionShow less

Excess, stored, HCV patients' plasma, serum and blood samples will be supplied by the Virology laboratory (Hull University Teaching Hospital's Trust; HUTH). These samples were taken and analysed as part of patients' clinical monitoring, and are stored prior to disposal in the Virology laboratory. The proposed study will use the samples in a fully anonymised manner.

The 2 groups in the trial

  • Test

    Hep C positive

  • Control

    Hep C negative

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Development of Point-of-care and Wearable Sensors for Hepatitis C Diagnostics
Record updated
10 July 2024